AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32004775
Drug: Therapeutic drug
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic drug monitoring (TDM) using a new HPLC-MS/MS method for quantifying dolutegravir (DTG), elvitegravir (ELV), rilpivirine (RPV), raltegravir (RAL), raltegravir‐Î²‐D‐glucuronide (RAL‐GLU), darunavir (DRV), and ritonavir (RTV) in human plasma.
Trial: 33923171
Drug: 12 g
RxNorm normalized name: PEG-12 GLYCERYL LAURATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 g of mixed soluble and insoluble fiber for 8 weeks
Trial: 32694162
Drug: Ferric Citrate
RxNorm normalized name: Ferric Citrate
DrugBank: Ferric sodium citrate (DB13771)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric Citrate (2 g three times a day with meals, n=30)
Trial: 32694162
Drug: Ferrous Sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous Sulfate (325 mg three times a day, n=30)
Trial: 35507383
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose of dexamethasone (0.6 mg/kg per dose, maximum of 16 mg)
Trial: 35507383
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of dexamethasone (0.6 mg/kg per dose, maximum of 16 mg)
Trial: 35507383
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose of dexamethasone
Trial: 35507383
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of dexamethasone
Trial: 34299697
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT) as an adjunctive to treatment-as-usual (TAU)
Trial: 32469095
Drug: Sponsor-provided drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sponsor-provided drugs
Trial: 32736928
Drug: Intravesical mitomycin
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravesical mitomycin C (40 mg/40 ml) three times a week for 2 weeks
Trial: 32736928
Drug: TURBT and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TURBT and six weekly adjuvant instillations
Trial: 36274158
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg progesterone daily for 4 days of abstinence
Trial: 34061838
Drug: GMZ2 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GMZ2 vaccine adjuvanted with Cationic Adjuvant Formulation (CAF) 01
Trial: 34061838
Drug: GMZ2 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GMZ2 vaccine adjuvanted with Alhydrogel
Trial: 34061838
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (Rabies)
Trial: 34167881
Drug: Combination supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination supplementation with vitamin B12 and folate
Trial: 35122992
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of trans-resveratrol per day for four weeks
Trial: 35122992
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 mg wheat flour) for four weeks
Trial: 33151315
Drug: TACE plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACE plus ablative therapy (stereotactic body radiation therapy, microwave ablation, radiofrequency ablation)
Trial: 33151315
Drug: TACE plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACE plus ablative therapy
Trial: 611775172
Drug: Intraperitoneal local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal local anesthetic (20 mL 0.25% or 0.125% bupivacaine)
Trial: 611775172
Drug: Control (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (20 mL 0.9% NaCl)
Trial: 35724745
Drug: Itrīfal Shāhtra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itrīfal Shāhtra (oral) and Marham Ḥina (topical)
Trial: 35724745
Drug: PUVAsol (oral)
RxNorm normalized name: docusate sodium / sennosides, USP Oral Tablet [Purgasol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUVAsol (oral) and petrolatum (topical)
Trial: 32416008
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment arms from CARE-HD
Trial: 33571946
Drug: sc IFN
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sc IFN β‐1a (22 or 44 μg, three-times-weekly)
Trial: 33687748
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec 100 U/mL (IDeg‐100)
Trial: 33378433
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) injections with CaCl2 activating solution
Trial: 33378433
Drug: CaCl2 injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CaCl2 injection only (control)
Trial: 33378433
Drug: Both PRP
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both PRP and CaCl2 injections
Trial: 33629461
Drug: no treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no treatment (negative control)
Trial: 33833224
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (Lupron)‐induced ovarian suppression
Trial: 35555329
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker (CCB) therapy (amlodipine)
Trial: 35555329
Drug: CCB +
RxNorm normalized name: Calcium Channel Blocker Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCB + ACE inhibitor therapy
Trial: 35555329
Drug: CCB +
RxNorm normalized name: Calcium Channel Blocker Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCB + ACE inhibitor + decreased salt intake
Trial: 35555329
Drug: All antihypertensive
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All antihypertensive therapies
Trial: 39500494
Drug: CytoSorb therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CytoSorb therapy
Trial: 35896261
Drug: Oral Vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Vitamin B12 500 μg/day
Trial: 35896261
Drug: Oral Vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Vitamin B12 1,500 μg/day
Trial: 36456016
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of oral azithromycin
Trial: 33766702
Drug: Individualized nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized nutritional counseling every 2 weeks during therapy
Trial: 32631586
Drug: estradiol 1
RxNorm normalized name: estradiol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: estradiol 1 mg combined with drospirenone 2 mg
Trial: 33836635
Drug: Azacitidine (AZA)
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine (AZA) and histone deacetylase inhibitors (HDACi) combination
Trial: 32930040
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy (CBT) for chronic fatigue syndrome
Trial: 33234323
Drug: Visuomotor therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Visuomotor therapy (active)
Trial: 35686576
Drug: Interdisciplinary graded
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interdisciplinary graded exposure treatment (GET Living)
Trial: 32989170
Drug: Combined Oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Oral Contraceptives (COC) (Triphasil or Nordette)
Trial: 33481828
Drug: Prism adaptation
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prism adaptation treatment (PAT)
Trial: 33481828
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (active control)
Trial: 36054480
Drug: Sacubitril/valsartan (97
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sacubitril/valsartan (97 mg of sacubitril and 103 mg of valsartan twice daily)
Trial: 36321459
Drug: Ramipril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (5 mg twice daily)
Trial: 35543939
Drug: Flunarizine hydrochloride
RxNorm normalized name: flunarizine hydrochloride
DrugBank: Flunarizine (DB04841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine hydrochloride capsule, 10 mg a day for 4 weeks
Trial: 35947864
Drug: Brief Solution
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Solution Focused Therapy (BSFT), 5 sessions over 3 months
Trial: 32933504
Drug: Febuxostat 40
RxNorm normalized name: febuxostat 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat 40 mg once daily
Trial: 32933504
Drug: Terminalia bellerica
RxNorm normalized name: Terminalia bellirica fruit extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terminalia bellerica (TBE) 500 mg twice daily
Trial: 32933504
Drug: Terminalia bellerica
RxNorm normalized name: Terminalia bellirica fruit extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terminalia bellerica (TBE) 1000 mg twice daily
Trial: 39452487
Drug: PCSK9 inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PCSK9 inhibitors
Trial: 35417958
Drug: Iron therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron therapy (1000 mg ferric carboxymaltose in 100 mL saline, infused slowly over 15 min 7 days before surgery)
Trial: 35417958
Drug: Placebo (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (100 mL saline, infused slowly over 15 min 7 days before surgery)
Trial: 34579112
Drug: Inulin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inulin (10 g/day)
Trial: 34579112
Drug: Placebo (maltodextrin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (maltodextrin, 10 g/day)
Trial: 36065810
Drug: Low-dose nelonemdaz
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nelonemdaz (2750 mg)
Trial: 36065810
Drug: High-dose nelonemdaz
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose nelonemdaz (5250 mg)
Trial: 34391264
Drug: Knitting program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knitting program (8-week duration) with bi-weekly 20-min group sessions and daily 20-min home sessions
Trial: 35507508
Drug: CoVLP+AS03 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoVLP+AS03 vaccine
Trial: 36100263
Drug: Extended duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended duration thromboprophylaxis using daily subcutaneous tinzaparin at 4500 IU for 56 days postoperatively
Trial: 36100263
Drug: Extended duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended duration thromboprophylaxis using daily subcutaneous tinzaparin at 4500 IU
Trial: 33230290
Drug: No-treatment delivered
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment delivered by VEx
Trial: 33230290
Drug: No-treatment delivered
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment delivered by text-only control
Trial: 33230290
Drug: Expectancy manipulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Expectancy manipulation (placebo or no-treatment)
Trial: 33230290
Drug: VEx regardless
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VEx regardless of treatment
Trial: 35564596
Drug: Antenatal corticosteroids
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal corticosteroids (two doses of IM dexamethasone 12 mg, 12 hours apart, 24 hours prior to surgery)
Trial: 32086819
Drug: Eculizumab (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eculizumab (single infusion)
Trial: 34807716
Drug: mRNA-1273 vaccine
RxNorm normalized name: SARS-CoV-2 mRNA-1273 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mRNA-1273 vaccine (third dose)
Trial: 36343880
Drug: Group-based Family-Based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based Family-Based Treatment (FBT)
Trial: 36343880
Drug: Guided self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-help Family-Based Treatment (gshFBT)
Trial: 32371430
Drug: FKB327 or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FKB327 or RP (with treatment switching)
Trial: 35552824
Drug: Oxabact (lyophilized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxabact (lyophilized O. formigenes formulation), administered orally, twice daily for 52 weeks.
Trial: 35552824
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered orally, twice daily for 52 weeks.
Trial: 35350970
Drug: START-Play physical
RxNorm normalized name: Star Anise Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: START-Play physical therapy intervention
Trial: 32379483
Drug: High-intensity ultrasonically
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity ultrasonically nebulized distilled water (UNDW) inhalations (1.6 ml/min)
Trial: 32379483
Drug: Low-intensity UNDW
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity UNDW inhalations (0.5 ml/min)
Trial: 32379483
Drug: Control, 0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control, 0.9% saline inhalations (1.6 ml/min)
Trial: 32519005
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline (HS) - 5 ml/kg body weight of 7.3% NaCl over 60 min
Trial: 32423706
Drug: Antidepressant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant therapy (combined with desmopressin if needed)
Trial: 32423706
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment including desmopressin
Trial: 34378862
Drug: Chlorhexidine gel
RxNorm normalized name: chlorhexidine Oral Gel
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gel 1% applied inside the implant hex
Trial: 32059705
Drug: De-escalated primary
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De-escalated primary radiotherapy (60 Gy) ± concomitant chemotherapy
Trial: 35870710
Drug: Pelvic radiotherapy
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic radiotherapy (50Gy prescription dose)
Trial: 32534807
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate with leucovorin rescue (HDMTX-LR)
Trial: 35102967
Drug: 4% articaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% articaine buccal infiltration
Trial: 36149216
Drug: Standard Triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Triple Therapy (sTT)
Trial: 36149216
Drug: Bismuth-Containing Quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth-Containing Quadruple Therapy (BQT)
Trial: 36149216
Drug: Hybrid Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid Therapy (HT)
Trial: 34161952
Drug: Bio-enhanced turmeric
RxNorm normalized name: Turmeric
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-enhanced turmeric formulation (BTF) 1 g/day
Trial: 34161952
Drug: Bio-enhanced turmeric
RxNorm normalized name: Turmeric
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-enhanced turmeric formulation (BTF) 1.5 g/day
Trial: 34161952
Drug: Bio-enhanced turmeric
RxNorm normalized name: Turmeric
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-enhanced turmeric formulation (BTF)
Trial: 32684633
Drug: Bortezomib-containing induction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bortezomib-containing induction therapy (IT), high-dose melphalan (MEL200), autologous blood stem cell transplantation (ASCT), consolidation, and maintenance with lenalidomide
Trial: 34278044
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (750 mg)
Trial: 39535683
Drug: Oral semaglutide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral semaglutide
Trial: 35381839
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg orally two hours before surgery and 24 hours after surgery
Trial: 33210787
Drug: Peri-implant diseases
RxNorm normalized name: PAD,PERI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peri-implant diseases
Trial: 39010171
Drug: Saline nasal
RxNorm normalized name: Ayr Saline Nasal
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline nasal spray (Control)
Trial: 35979901
Drug: 15-mL oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-mL oral solution of aspirin (300 mg)
Trial: 35979901
Drug: Chewed aspirin
RxNorm normalized name: aspirin Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewed aspirin tablet (300 mg)
Trial: 33986063
Drug: Cream cracker
RxNorm normalized name: crack willow pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream cracker
Trial: 33742282
Drug: Control playgroup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control playgroup (following cognitive-behavioral therapy for PND)
Trial: 35170885
Drug: Prayer (reciting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prayer (reciting for 10 minutes three times daily)
Trial: 35170885
Drug: Ginger (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (250 mg capsules plus 20 ml water after each meal)
Trial: 35170885
Drug: Control (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (placebo starch capsules, 250 mg daily)
Trial: 32366241
Drug: Rectal STI
RxNorm normalized name: STI-1499
DrugBank: STI-1499 (DB16487)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal STI test selection
Trial: 34698704
Drug: Infant Mental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant Mental Health Home Visiting (IMH‐HV) treatment
Trial: 33682353
Drug: Biologic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biologic therapy (a biologic disease-modifying antirheumatic drug plus methotrexate)
Trial: 33682353
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (methotrexate plus sulfasalazine plus hydroxychloroquine/chloroquine)
Trial: 34440974
Drug: Virtual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual therapy (VR) in an eight-week cardiac rehabilitation program
Trial: 35307850
Drug: P22-TAB (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P22-TAB (250 mg)
Trial: 35307850
Drug: P22-CAP (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P22-CAP (250 mg)
Trial: 35307850
Drug: P01-CAP (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P01-CAP (250 mg)
Trial: 34890377
Drug: 10 days
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days antibiotic therapy (SDR group)
Trial: 34890377
Drug: 14 days
RxNorm normalized name: ponesimod
DrugBank: Ponesimod (DB12016)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 14 days antibiotic therapy (LDR group)
Trial: 33635894
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment for two weeks
Trial: 34925204
Drug: Transcranial direct
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial direct current stimulation (tDCS) combined with conventional, individualised rehabilitation therapy.
Trial: 34925204
Drug: Conventional, individualised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional, individualised rehabilitation therapy (Control group).
Trial: 33891570
Drug: Acupressure on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupressure on three acupuncture points (LI4, SP6, ST36) for three minutes twice daily for four weeks
Trial: 33618735
Drug: Existing preschool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Existing preschool oral healthcare programme (POHP)
Trial: 33308257
Drug: TB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TB treatment adherence intervention (educational outreach, point-of-care reminder tool, peer support network)